ISAR-REACT 5 Trial: Ticagrelor vs Prasugrel in ACS
Background: In patients presenting to the ED with acute coronary syndrome (ACS), dual antiplatelet therapy is the current standard treatment. This typically consists of aspirin and an adenosine diphosphate receptor...
Marco Torres |